Search

Author/Creator Messersmith, W. A.

1. A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer. (3rd March 2016)

Authors:
O'Neil, B. H.; Scott, A. J.; Ma, W. W.; Cohen, S. J.; Aisner, D. L.; Menter, A. R.; Tejani, M. A.; Cho, J. K.; Granfortuna, J.; Coveler, A. L.; Olowokure, O. O.; Baranda, J. C.; Cusnir, M.; Phillip, P.; Boles, J.; Nazemzadeh, R.; Rarick, M.; Cohen, D. J.; Radford, J.; Fehrenbacher, L.
Journal:
Annals of oncology
Issue:
Volume 27:Number 6(2016:Jun.)
Page Start:
1180
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts. Issue 1 (8th February 2019)

Authors:
Capasso, A.; Lang, J.; Pitts, T. M.; Jordan, K. R.; Lieu, C. H.; Davis, S. L.; Diamond, J. R.; Kopetz, S.; Barbee, J.; Peterson, J.; Freed, B. M.; Yacob, B. W.; Bagby, S. M.; Messersmith, W. A.; Slansky, J. E.; Pelanda, R.; Eckhardt, S. G.
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 7:Issue 1(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search